Skip to main content
Top
Published in: Reactions Weekly 1/2016

01-08-2016 | Case report

Simeprevir/sofosbuvir

Various toxicity: case report

Published in: Reactions Weekly | Issue 1/2016

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Safadi R, et al. Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevir. Clinical Case Reports 4: 653-656, No. 7, 01 Jul 2016. Available from: URL: http://doi.org/10.1002/ccr3.581 - IsraelCrossRefPubMedPubMedCentral Safadi R, et al. Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevir. Clinical Case Reports 4: 653-656, No. 7, 01 Jul 2016. Available from: URL: http://​doi.​org/​10.​1002/​ccr3.​581 - IsraelCrossRefPubMedPubMedCentral
Metadata
Title
Simeprevir/sofosbuvir
Various toxicity: case report
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2016
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-20758-2

Other articles of this Issue 1/2016

Reactions Weekly 1/2016 Go to the issue

Case report

Methylphenidate

Case report

Meropenem

Case report

Hydroxycarbamide

Case report

Iodine-131